Cloned (Comment) | Organism |
---|---|
TDP1 overexpression in U2-OS cells | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | knocking down TDP1 in cells expressing a dominant negative form of PARP1 and co-silencing of TDP1 and the checkpoint control gene RAD17, overview | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
IGROV-1 cell | - |
Homo sapiens | - |
ovary cancer cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
TDP1 | - |
Homo sapiens |
tyrosyl-DNA phosphodiesterase 1 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
assay at | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
metabolism | TDP1 knockdown does not produce a change in sensitivity to camptothecin, whereas co-silencing of other pathways cooperating with TDP1 in cell response to topoisomerase I poisons indicates that XRCC1 and BRCA1 are major regulators of sensitivity | Homo sapiens |
additional information | knockdown of the enzyme TDP1 in U2-OS cells does not increase sensitivity to gimatecan | Homo sapiens |
physiological function | tyrosyl-DNA phosphodiesterase 1 plays a unique function as it catalyzes the repair of topoisomerase I-mediated DNA damage. TDP1 alone can account for mild levels of camptothecin resistance, repair of topoisomerase I-mediated DNA damage likely occurs through redundant pathways mainly implicating BRCA1 and XRCC1, but not RAD17 and PARP1 | Homo sapiens |